Clarissa E. Jordan, MD Profile picture
Chief Resident🔜#HemePath fellow @MayoClinicPath🔬MD @bcmhouston👩🏻‍⚕️Bioinf/CS @baylorecs👩🏻‍💻 #CouplesMatch advocate💌#ASCP40UnderForty #PathTweetAward2022
Jul 13, 2022 11 tweets 4 min read
If you follow me, you know I love tweeting about #HemePath and lately #AML subtypes🩸

So far, I’ve covered the subtypes of AML with recurrent genetic abnormalities (per WHO 2016) - see below if you’re interested! ⬇️

Looking forward to more HemePath #tweetorials in the future! Image AML with mutated NPM1
Mar 2, 2022 11 tweets 6 min read
🩸#HemePath AML subtype #PathTweetorial 🧵

Which cytogenetic/molecular finding is most consistent with this morphology? (Poll⬇️)

#PathTwitter #MolecularPath #MedEd @MayoClinicPath
(P.S. Always learning - I welcome any feedback!) ImageImage Which cytogenetic/molecular finding is most consistent with this morphology? AML with…
Jan 15, 2022 11 tweets 7 min read
Hey #path2path #PathMatch22 applicants! Thinking about your rank list and wondering what📍Rochester, Minnesota is like?

In a word, beautiful 😍

A 🧵 for those who won’t get a chance to visit us this #virtual interview season! @MayoClinicPath @MayoClinic Just to get it out of the way…

YES, it gets cold here 🥶❄️ Yes, it snows 🌨

But as someone who grew up in the desert ➡️ and then lived in TX 🤠 ➡️ if I can handle it, you definitely can too! (Just need to get yourself some good gear🧥🥾 - I’ve got suggestions!)
Sep 28, 2021 15 tweets 6 min read
Catching up on 🧬 “Understanding #NGS and Interpreting Reports for Oncologic Pathology” with Dr. @sabahkadri and Dr. Cecilia Yeung at #CAP21 @AMPath 👩🏻‍💻

Super useful talk with excellent case studies! Here are just a few takeaways 🧵⬇️ #MolecularPath_CEJ #Informatics_CEJ 🤔 Considerations in developing an NGS assay

📌 @Pathologists has NGS assay development tools regarding test design, validation, quality, and bioinformatics: cap.org/member-resourc…
📌 How much do you want to know? ➡️ what test is needed? (WGS vs WES vs targeted sequencing)

1/
Sep 28, 2021 18 tweets 5 min read
🧬#MolecularPath “Selecting the Right Tool for the Job: Practical Considerations for the Application of Molecular Diagnostics Methods in SurgPath” with @LJTafeMD and Dr. Larissa Furtado

A few takeaways (just scratching the surface of this excellent talk!) ⬇️🧵#MolecularPath_CEJ Image First up: Pre-analytical Considerations

Purposes of molecular oncology testing:

🔵 Diagnosis
🔵 Therapy response/management
🔵 Monitoring

1/